Skip to content

Clinical trials

Phase 4 Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Phase: Phase 4 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20073
20081
20103
20111
20123
20131
20151
20213
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Not yet recruiting1
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Kim's Eye Hospital2
Novartis2
Vista Klinik2
Brandon G. Busbee, MD1
Federal University of São Paulo1
Hospital Authority, Hong Kong1
Oklahoma State University Center for Health Sciences1
Pfizer1
Pusan National University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization22
Macular Degeneration16
Vision Disorders4
Wet Macular Degeneration4
Geographic Atrophy3
Eye Diseases2
Macular Edema2
Retinal Degeneration2
Retinal Detachment2
Retinal Diseases2

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.